跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PANVAX pandemic influenza vaccine, adjuvanted 10 ml suspension for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PANVAX pandemic influenza vaccine, adjuvanted 10 ml suspension for injection vial
Approved
STANDARD
PANVAX pandemic influenza vaccine, adjuvanted 10 ml suspension for injection vial
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
743d7eba055ea38e
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
743d7eba055ea38e
Product Name
PANVAX pandemic influenza vaccine, adjuvanted 10 ml suspension for injection vial
Artg Id
137704
Artg Name
PANVAX pandemic influenza vaccine, adjuvanted 10 ml suspension for injection vial
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2008-06-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
743d7eba055ea38e
Type
Standard
Back to TGA Approvals